A strong horticultural heritage, a strong pharma sector, combined with progressive and clear legislation for production of medical cannabis made Denmark a first mover in Europe.
Brazilian pharmaceutical regulator Anvisa approved regulations yesterday for the roll-out of medicinal cannabis-based products. Although, in a separate vote Anvisa blocked a proposal to allow domestic medical marijuana cultivation while a judge authorized industrial hemp cultivation by a specific company.
One company is aiming to put a halt to the cannabis medicine shortage; Australian startup, Canngea, is vying to address the problem by setting up Australia’s largest pharmaceutical grade indoor facility to grow and manufacture high quality medical cannabis products.
The UK’s first university-backed cultivation of cannabis for medical research is under way at a secret location in Somerset.
The MyAccess service in Redland Court Road’s May Wellness Centre is only the second medical cannabis clinic in the UK to get a licence, which the CQC announced last night (November 13).